NSC expo
Subscribe or Register
View Cart  

Earn recertification points from the Board of Certified Safety Professionals by taking a quiz about this issue.

What's Your Opinion?

Should employers' injury and illness data be made public?

Take the poll and add your comment.

Vote   Results


Does your CEO 'Get it?'

Tell us why on the submission form and your CEO could appear among the 2017 selections.

Get the news that's
important to you.

Sign up for Safety+Health’s free monthly newsletters on:

  • Construction
  • Health Care Workers
  • Manufacturing
  • Mining, Oil and Gas
  • Office Safety Tips
  • Transportation
  • Worker Health and Wellness
  • Subscribe today

    FRA expands post-crash testing for certain pain, allergy meds

    March 13, 2013

    • / Print
    • Reprints
    • Text Size:
      A A

    Washington – Post-crash testing of railroad workers for certain non-controlled drugs that may cause drowsiness and dizziness will begin May 6, the Federal Railroad Administration recently announced (.pdf file). FRA already tests railroad workers for alcohol and controlled substances such as marijuana and amphetamines.

    The agency will first begin testing for tramadol – a type of non-narcotic pain reliever – and non-prescription antihistamines with sedating ingredients, such as Benadryl. Test results will be kept confidential while FRA continues to research whether these drugs’ side effects significantly affect rail safety.

    FRA is accepting petitions for reconsideration until May 6, and comments on any received petitions are due June 18.

    Post a comment to this article

    Safety+Health welcomes comments that promote respectful dialogue. Please stay on topic. Comments that contain personal attacks, profanity or abusive language – or those aggressively promoting products or services – will be removed. We reserve the right to determine which comments violate our comment policy.